Panretinal photocoagulation (PRP) is a common procedure in ophthalmology used to treat proliferative diabetic retinopathy (PDR) and other conditions causing retinal neovascularization. During PRP, a laser is applied to the peripheral areas of the retina to create hundreds of small burns. This helps reduce abnormal blood vessel growth and prevents them from bleeding or causing retinal detachment, which are severe complications of PDR. The procedure typically takes place over multiple sessions to treat the entire peripheral retina while preserving central vision.
PRP aims to preserve vision and prevent further deterioration in patients with advanced diabetic eye disease. Although it can cause some temporary side effects like blurry vision or reduced night vision, PRP is highly effective in stabilizing the retina and preventing severe vision loss in diabetic patients at risk of blindness. Regular follow-ups are crucial to monitor the retina's response and ensure optimal outcomes.
Background: Pan-retinal laser photocoagulation (PRP) is used in the management of diabetic retinopathy, aimed at preventing the growth of abnormal blood vessels in the retina and reducing the risk of…
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Oral and poster slots for original Panretinal Photocoagulation work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping Panretinal Photocoagulation research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Panretinal Photocoagulation track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Panretinal Photocoagulation. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Panretinal Photocoagulation are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the Panretinal Photocoagulation track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
